16 nuovi farmaci in commercio
Nuove specialità medicinali
CONGEXAM 30 cpr 5 mg + 5 mg bisoprololo fumarato/amlodipina besilato
MERCK SERONO AIC:049919020 7,13€ A/RR in commercio dal:19/05/2025
DIETRA 4 cps molli 25.000 Unita' Internazionali colecalciferolo
PHARMACARE AIC:046177073 6,32€ A/RR in commercio dal:15/05/2025
DIFFERIN gel derm 50 g 0,1 % adapalene
GALDERMA AIC:029309073 45,95€ C/RR in commercio dal:15/05/2025
Nuovi farmaci equivalenti
LEVOSIMENDAN WAYMADE 1 flaconcino EV 5 ml 2,5 mg/ml levosimendan
WAYMADE AIC:051156014 1.485,00€ C/OSP in commercio dal:26/05/2025
MARAVIROC WAYMADE 60 cpr riv 150 mg maraviroc
WAYMADE AIC:050714017 938,37€ H/RNRL in commercio dal:15/05/2025
METFORMINA EG STADA ITALIA 40 cpr riv 850 mg metformina cloridrato
EG AIC:049629064 2,53€ A/RR in commercio dal:13/05/2025
OLMESARTAN MEDOXOMIL E AMLODIPINA MYLAN ITALIA 28 cpr riv 20 mg + 5 mg olmesartan medoxomil/amlodipina besilato
MYLAN AIC:051592018 9,13€ A/RR in commercio dal:16/05/2025
OLMESARTAN MEDOXOMIL E AMLODIPINA MYLAN ITALIA 28 cpr riv 40 mg + 10 mg olmesartan medoxomil/amlodipina besilato
MYLAN AIC:051592032 10,00€ A/RR in commercio dal:16/05/2025
OLMESARTAN MEDOXOMIL E AMLODIPINA MYLAN ITALIA 28 cpr riv 40 mg + 5 mg olmesartan medoxomil/amlodipina besilato
MYLAN AIC:051592020 9,13€ A/RR in commercio dal:16/05/2025
POMALIDOMIDE GRINDEKS 21 cps 1 mg pomalidomide
AS GRINDEKS AIC:051079010 9.780,88€ Cnn/RNRL in commercio dal:19/05/2025
POMALIDOMIDE GRINDEKS 21 cps 2 mg pomalidomide
AS GRINDEKS AIC:051079022 9.780,88€ Cnn/RNRL in commercio dal:19/05/2025
POMALIDOMIDE GRINDEKS 21 cps 3 mg pomalidomide
AS GRINDEKS AIC:051079034 9.780,88€ Cnn/RNRL in commercio dal:19/05/2025
POMALIDOMIDE GRINDEKS 21 cps 4 mg pomalidomide
AS GRINDEKS AIC:051079046 9.780,88€ Cnn/RNRL in commercio dal:19/05/2025
RAMIPRIL ALTER 14 cpr 5 mg ramipril LABORATORI
ALTER AIC:050238118 2,17€ A/RR in commercio dal:16/05/2025
RAMIPRIL ALTER 28 cpr 10 mg ramipril LABORATORI
ALTER AIC:050238171 5,69€ A/RR in commercio dal:16/05/2025
RAMIPRIL ALTER 28 cpr 5 mg ramipril LABORATORI
ALTER AIC:050238120 3,28€ A/RR in commercio dal:16/05/2025
Altri articoli della sezione Italia

Ictus ischemico acuto, Aifa approva la rimborsabilitā di tenecteplase 25 mg per il trattamento en...

Approvato da Aifa il primo trattamento orale che migliora la fatigue nell'emoglobinuria parossist...

26 nuovi farmaci in commercio

6 cessate commercializzazioni

9 variazioni di prezzo
